These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16557215)

  • 21. Colorectal cancer test use from the 2005 National Health Interview Survey.
    Shapiro JA; Seeff LC; Thompson TD; Nadel MR; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1623-30. PubMed ID: 18628413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in up-to-date status in colorectal cancer screening, North Carolina, 1998-2002.
    Kim JA; Porterfield D; Gizlice Z
    N C Med J; 2005; 66(6):420-6. PubMed ID: 16438098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in colorectal cancer screening and prevention.
    Pignone M; Levin B
    Am Fam Physician; 2002 Jul; 66(2):297-302. PubMed ID: 12152966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
    Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS).
    Bradbury BD; Brooks DR; Brawarsky P; Mucci LA
    Prev Med; 2005 Jul; 41(1):303-11. PubMed ID: 15917026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer screening, 1997-1999: role of income, insurance and policy.
    Adams EK; Thorpe KE; Becker ER; Joski PJ; Flome J
    Prev Med; 2004 May; 38(5):551-7. PubMed ID: 15066357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010.
    Joseph DA; King JB; Miller JW; Richardson LC;
    MMWR Suppl; 2012 Jun; 61(2):51-6. PubMed ID: 22695464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening: physician recommendation is influential advice to Marylanders.
    Gilbert A; Kanarek N
    Prev Med; 2005 Aug; 41(2):367-79. PubMed ID: 15917034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal carcinoma: causes, diagnosis, and prevention.
    Bedine MS
    Compr Ther; 1990 Jan; 16(1):14-8. PubMed ID: 2406104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening and surveillance.
    Harford WV
    Surg Oncol Clin N Am; 2006 Jan; 15(1):1-20, v. PubMed ID: 16389147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hispanic acculturation and utilization of colorectal cancer screening in the United States.
    Shah M; Zhu K; Potter J
    Cancer Detect Prev; 2006; 30(3):306-12. PubMed ID: 16872756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New screening guidelines for colorectal cancer: a practical guide for the primary care physician.
    Allison JE; Potter MB
    Prim Care; 2009 Sep; 36(3):575-602. PubMed ID: 19616156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
    Stock C; Brenner H
    Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.